As of 2023, the mortality rate for malignant neoplasms in Germany stood at a certain benchmark. Forecasted data from 2024 to 2028 shows a slight increase, stabilizing around 278.2 to 278.3 deaths per hundred thousand persons. The data suggests no significant year-on-year variations, indicating a plateau. Over a five-year period (2024-2028), the compound annual growth rate (CAGR) remains minimal, reflecting a steady rate with negligible growth.
Future trends to watch for include advancements in medical technology and healthcare policies that could potentially lower mortality rates. Monitoring lifestyle changes and preventative healthcare measures will be essential in addressing this stagnation.
